ALNY - Alnylam reports positive Phase 2 data for hypertension drug
2023-11-13 09:17:37 ET
More on Alnylam Pharmaceuticals
- Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2023 Earnings Call Transcript
- Alnylam Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Alnylam Pharmaceuticals: A Good Buy Ahead Of Phase 3 Data For Vutrisiran
- Alnylam Pharmaceuticals beats Q3 top and bottom line estimates; updates FY23 outlook
- Alnylam Pharmaceuticals Q3 2023 Earnings Preview
For further details see:
Alnylam reports positive Phase 2 data for hypertension drug